Nagato Kuriyama

Genetic determinants of malignancy in a mouse model for oligodendroglioma.

William A. Weiss, Michael J. Burns, Christopher S. Hackett et al. · PubMed · 2003 · 175 citations

Medicine, Genetics, Oncology +17

Dynamic contrast‐enhanced magnetic resonance imaging as a surrogate marker of tumor response to anti‐angiogenic therapy in a xenograft model of glioblastoma multiforme

Thomas H. Helbich, Nagato Kuriyama, Susanne Ostrowitzki et al. · Journal of Magnetic Resonance Imaging · 2002 · 155 citations

Medicine, Oncology, Biomedical Imaging +15

Pretreatment with Protease Is a Useful Experimental Strategy for Enhancing Adenovirus-Mediated Cancer Gene Therapy

Nagato Kuriyama, Hiroko Kuriyama, Carol M. Julin et al. · Human Gene Therapy · 2000 · 76 citations

Pharmacy, Molecular Biology, Oncology +14

Protease pretreatment increases the efficacy of adenovirus-mediated gene therapy for the treatment of an experimental glioblastoma model.

Nagato Kuriyama, Hiroko Kuriyama, Carol M. Julin et al. · PubMed · 2001 · 59 citations

Medicine, Cancer Biology, Oncology +14

Prognostic significance of an apoptotic index and apoptosis/proliferation ratio for patients with high-grade astrocytomas

Hiroko Kuriyama, Kathleen R. Lamborn, Judith R. OʼFallon et al. · Neuro-Oncology · 2002 · 42 citations · Full text

Medicine, Oncology, Pathology +16